Antagonistic crosstalk between type I and II interferons and increased host susceptibility to bacterial infections

References

• Huang S, Hendriks W, Althage A, Hemmi S, Bluethmann H, Kamijo R, et al. Immune response in mice that lack the interferon-gamma receptor. Science 1993; 259:1742 - 1745
   PubMed Web of Science ®Google Scholar
• Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 1993; 178:2243 - 2247
   PubMed Web of Science ®Google Scholar
• Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA. Multiple defects of immune cell function in mice with disrupted interferongamma genes. Science 1993; 259:1739 - 1742
   PubMed Web of Science ®Google Scholar
• Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993; 178:2249 - 2254
   PubMed Web of Science ®Google Scholar
• Newport MJ, Huxley CM, Huston S, Hawrylowicz CM, Oostra BA, Williamson R, et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996; 335:1941 - 1949
   PubMed Web of Science ®Google Scholar
• Jouanguy E, Altare F, Lamhamedi S, Revy P, Emile JF, Newport M, et al. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N Engl J Med 1996; 335:1956 - 1961
   PubMed Web of Science ®Google Scholar
• Lu B, Ebensperger C, Dembic Z, Wang Y, Kvatyuk M, Lu T, et al. Targeted disruption of the interferon-gamma receptor 2 gene results in severe immune defects in mice. Proc Natl Acad Sci USA 1998; 95:8233 - 8238
   PubMed Web of Science ®Google Scholar
• Dorman SE, Holland SM. Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. J Clin Invest 1998; 101:2364 - 2369
   PubMed Web of Science ®Google Scholar
• Koch O, Kwiatkowski DP, Udalova IA. Context-specific functional effects of IFNGR1 promoter polymorphism. Hum Mol Genet 2006; 15:1475 - 1481
   PubMed Web of Science ®Google Scholar
• Bulat-Kardum L, Etokebe GE, Knezevic J, Balen S, Matakovic-Mileusnic N, Zaputovic L, et al. Interferon-gamma receptor-1 gene promoter polymorphisms (G-611A; T-56C) and susceptibility to tuberculosis. Scand J Immunol 2006; 63:142 - 150
   PubMed Web of Science ®Google Scholar
• Cooke GS, Campbell SJ, Sillah J, Gustafson P, Bah B, Sirugo G, et al. Polymorphism within the interferon-gamma/receptor complex is associated with pulmonary tuberculosis. Am J Respir Crit Care Med 2006; 174:339 - 343
   PubMed Web of Science ®Google Scholar
• Shi S, Blumenthal A, Hickey CM, Gandotra S, Levy D, Ehrt S. Expression of many immunologically important genes in Mycobacterium tuberculosis-infected macrophages is independent of both TLR2 and TLR4 but dependent on IFN-alphabeta receptor and STAT1. J Immunol 2005; 175:3318 - 3328
   PubMed Web of Science ®Google Scholar
• Stanley SA, Johndrow JE, Manzanillo P, Cox JS. The Type I IFN response to infection with Mycobacterium tuberculosis requires ESX-1-mediated secretion and contributes to pathogenesis. J Immunol 2007; 178:3143 - 3152
   PubMed Web of Science ®Google Scholar
• Crimmins GT, Herskovits AA, Rehder K, Sivick KE, Lauer P, Dubensky T Jr, et al. Listeria monocytogenes multidrug resistance transporters activate a cytosolic surveillance pathway of innate immunity. Proc Natl Acad Sci USA 2008; 105:10191 - 10196
   PubMed Web of Science ®Google Scholar
• Stetson DB, Medzhitov R. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 2006; 24:93 - 103
   PubMed Web of Science ®Google Scholar
• McWhirter SM, Barbalat R, Monroe KM, Fontana MF, Hyodo M, Joncker NT, et al. A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMP. J Exp Med 2009; 206:1899 - 1911
   PubMed Web of Science ®Google Scholar
• Woodward JJ, Iavarone AT, Portnoy DA. c-di-AMP Secreted by Intracellular Listeria monocytogenes Activates a Host Type I Interferon Response. Science 2010; 328:1703 - 1705
   PubMed Web of Science ®Google Scholar
• Fehr T, Schoedon G, Odermatt B, Holtschke T, Schneemann M, Bachmann MF, et al. Crucial role of interferon consensus sequence binding protein, but neither of interferon regulatory factor 1 nor of nitric oxide synthesis for protection against murine listeriosis. J Exp Med 1997; 185:921 - 931
   PubMedGoogle Scholar
• Carrero JA, Calderon B, Unanue ER. Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to listeria infection. J Exp Med 2004; 200:535 - 540
   PubMed Web of Science ®Google Scholar
• O'Connell RM, Saha SK, Vaidya SA, Bruhn KW, Miranda GA, Zarnegar B, et al. Type I Interferon Production Enhances Susceptibility to Listeria monocytogenes Infection. J Exp Med 2004; 200:437 - 445
   PubMed Web of Science ®Google Scholar
• Auerbuch V, Brockstedt DG, Meyer-Morse N, O'Riordan M, Portnoy DA. Mice Lacking the Type I Interferon Receptor Are Resistant to Listeria monocytogenes. J Exp Med 2004; 200:527 - 533
   PubMed Web of Science ®Google Scholar
• Manca C, Tsenova L, Bergtold A, Freeman S, Tovey M, Musser JM, et al. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha/beta. Proc Natl Acad Sci USA 2001; 98:5752 - 5757
   PubMed Web of Science ®Google Scholar
• Jia T, Leiner I, Dorothee G, Brandl K, Pamer EG. MyD88 and Type I interferon receptor-mediated chemokine induction and monocyte recruitment during Listeria monocytogenes infection. J Immunol 2009; 183:1271 - 1278
   Google Scholar
• Carrero JA, Calderon B, Unanue ER. Lymphocytes are detrimental during the early innate immune response against Listeria monocytogenes. J Exp Med 2006; 203:933 - 940
   PubMed Web of Science ®Google Scholar
• Rayamajhi M, Humann J, Penheiter K, Andreasen K, Lenz LL. Induction of IFN-alphabeta enables Listeria monocytogenes to suppress macrophage activation by IFN-gamma. J Exp Med 2010; 207:327 - 337
   PubMed Web of Science ®Google Scholar
• Fortune SM, Solache A, Jaeger A, Hill PJ, Belisle JT, Bloom BR, et al. Mycobacterium tuberculosis inhibits macrophage responses to IFN-gamma through myeloid differentiation factor 88-dependent and -independent mechanisms. J Immunol 2004; 172:6272 - 6280
   PubMed Web of Science ®Google Scholar
• Pai RK, Pennini ME, Tobian AA, Canaday DH, Boom WH, Harding CV. Prolonged toll-like receptor signaling by Mycobacterium tuberculosis and its 19-kilodalton lipoprotein inhibits gamma interferon-induced regulation of selected genes in macrophages. Infect Immun 2004; 72:6603 - 6614
   PubMed Web of Science ®Google Scholar
• Pennini ME, Pai RK, Schultz DC, Boom WH, Harding CV. Mycobacterium tuberculosis 19 kDa lipoprotein inhibits IFN-gamma-induced chromatin remodeling of MHC2TA by TLR2 and MAPK signaling. J Immunol 2006; 176:4323 - 4330
   PubMed Web of Science ®Google Scholar
• Benson SA, Ernst JD. TLR2-dependent inhibition of macrophage responses to IFN-gamma is mediated by distinct, gene-specific mechanisms. PLoS One 2009; 4:6329
   Web of Science ®Google Scholar
• Ling PD, Warren MK, Vogel SN. Antagonistic effect of interferon-beta on the interferon-gamma-induced expression of Ia antigen in murine macrophages. J Immunol 1985; 135:1857 - 1863
   PubMed Web of Science ®Google Scholar
• Inaba K, Kitaura M, Kato T, Watanabe Y, Kawade Y, Muramatsu S. Contrasting effect of alpha/beta- and gamma-interferons on expression of macrophage Ia antigens. J Exp Med 1986; 163:1030 - 1035
   PubMed Web of Science ®Google Scholar
• Fertsch D, Schoenberg DR, Germain RN, Tou JY, Vogel SN. Induction of macrophage Ia antigen expression by rIFN-gamma and downregulation by IFN-alpha/beta and dexamethasone are mediated by changes in steady-state levels of Ia mRNA. J Immunol 1987; 139:244 - 249
   PubMed Web of Science ®Google Scholar
• Fertsch-Ruggio D, Schoenberg DR, Vogel SN. Induction of macrophage Ia antigen expression by rIFN-gamma and downregulation by IFN-alpha/beta and dexamethasone are regulated transcriptionally. J Immunol 1988; 141:1582 - 1589
   PubMed Web of Science ®Google Scholar
• Yoshida R, Murray HW, Nathan CF. Agonist and antagonist effects of interferon alpha and beta on activation of human macrophages. Two classes of interferon gamma receptors and blockade of the high-affinity sites by interferon alpha or beta. J Exp Med 1988; 167:1171 - 1185
   PubMed Web of Science ®Google Scholar
• Qiu H, Fan Y, Joyee AG, Wang S, Han X, Bai H, Jiao L, et al. Type I IFNs enhance susceptibility to Chlamydia muridarum lung infection by enhancing apoptosis of local macrophages. J Immunol 2008; 181:2092 - 2102
   Google Scholar
• Nagarajan UM, Prantner D, Sikes JD, Andrews C Jr, Goodwin AM, Nagarajan S, et al. Type I interferon signaling exacerbates Chlamydia muridarum genital infection in a murine model. Infect Immun 2008; 76:4642 - 4648
   PubMed Web of Science ®Google Scholar
• Martin FJ, Gomez MI, Wetzel DM, Memmi G, O'Seaghdha M, Soong G, et al. Staphylococcus aureus activates type I IFN signaling in mice and humans through the Xr repeated sequences of protein A. J Clin Invest 2009; 119:1931 - 1939
   PubMed Web of Science ®Google Scholar
• Shahangian A, Chow EK, Tian X, Kang JR, Ghaffari A, Liu SY, et al. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J Clin Invest 2009; 119:1910 - 1920
   PubMed Web of Science ®Google Scholar
• Henry T, Kirimanjeswara GS, Ruby T, Jones JW, Peng K, Perret M, et al. Type I IFN signaling constrains IL-17A/F secretion by gammadelta T cells during bacterial infections. J Immunol 2010; 184:3755 - 3767
   PubMed Web of Science ®Google Scholar
• Antonelli LR, Gigliotti Rothfuchs A, Goncalves R, Roffe E, Cheever AW, Bafica A, et al. Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population. J Clin Invest 2010; 120:1674 - 1682
   PubMed Web of Science ®Google Scholar
• Desvignes L, Ernst JD. Interferon-gamma-responsive nonhematopoietic cells regulate the immune response to Mycobacterium tuberculosis. Immunity 2009; 31:974 - 985
   PubMed Web of Science ®Google Scholar
• Axtell RC, de Jong BA, Boniface K, van der Voort LF, Bhat R, De Sarno P, et al. T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis. Nat Med 2010; 16:406 - 412
   PubMed Web of Science ®Google Scholar